In a controlled clinical setting (STEP 1 trial), participants with obesity who were prescribed semaglutide in combination with a structured lifestyle program lost an average of 14.9% of their body weight over 68 weeks
Patients should be asked about the use of other medications and medical conditions, which may exacerbate gastrointestinal symptoms and delay gastric emptying, such as, but not limited to bowel dysmotility, gastroparesis, and Parkinsons disease
In a major study, people using Wegovy (semaglutide) lost an average of 15% of their body weight over 68 weeks compared to those who didn't use the medication
Mills PJ, Ziegler MG, Morrison TA
But the healthy thyroid gland creates 4 different thyroid hormones, 3 of which perform different functions and actions